Shandong Yibao Biologics Co., Ltd
Shandong Yibao Biologics Co., Ltd is a high-tech manufacturing enterprise located in Jining, Shandong Province, China. Founded in 2002, the company focuses on the research, production, and sales of chondroitin sulfate series and related health care products, offering OEM services for oral liquids, softgels, capsules, tablets, granules, and powders. The facility spans approximately 30,000 square meters, supported by a workforce of over 300 staff, including a technical team with more than 20 professionals holding intermediate or higher qualifications.
In line with its growth strategy and expanding industrial chain, the company invested more than 300 million RMB in the Jining Food Industrial Park to establish a new large-scale research and production plant measuring about 200,000 square meters, a project completed in 2012. The new facility is designed to meet rising demand from both domestic and international customers and is equipped with first-class production equipment sourced domestically and from overseas.
Yibao Biologics operates more than 12 production lines dedicated to oral liquids, softgels, capsules, tablets, granules, and powders. Production capacities include approximately 500,000 daily servings for oral liquids, 1.5 million daily units for softgels and capsules, 1.5 million daily units for tablets, and 1.3 million bags daily for granules.
The company adheres to a quality-first philosophy, continually refining its production processes and investing in technological innovation. It maintains ISO 9001 Quality Management System certification and ISO 22000 Food Safety Management certification, underscoring its commitment to quality and safety. Additionally, Yibao Biologics has obtained the Health Certificate Enrollment in China Entry-Exit Inspection and Quarantine, reflecting compliance with regulatory standards for health-related products.
As a modern biotech and pharmaceutical enterprise, Shandong Yibao Biologics Co., Ltd aims to deliver reliable health care solutions through rigorous manufacturing practices, scientific development, and a robust OEM infrastructure that serves both domestic and international markets.